Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 24408051)

Published in Endocrine on January 10, 2014

Authors

Henrik Falhammar1, Helena Filipsson Nyström, Marja Thorén

Author Affiliations

1: Department of Endocrinology, Metabolism and Diabetes, D02:04, Karolinska University Hospital, 171 76, Stockholm, Sweden, henrik.falhammar@ki.se.

Articles by these authors

Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J Clin Endocrinol Metab (2009) 1.39

Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2007) 1.36

Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab (2006) 1.14

Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J Clin Endocrinol Metab (2007) 1.08

Incidence of hyperthyroidism in Sweden. Eur J Endocrinol (2011) 1.07

Adrenal incidentaloma - follow-up results from a Swedish prospective study. Eur J Endocrinol (2006) 0.98

Fracture incidence in GH-deficient patients on complete hormone replacement including GH. J Bone Miner Res (2007) 0.97

Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur J Endocrinol (2013) 0.96

Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol (2004) 0.96

Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception. J Clin Endocrinol Metab (2010) 0.92

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol (2010) 0.92

National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab (2013) 0.89

Thyrotoxic periodic paralysis: clinical and molecular aspects. Endocrine (2012) 0.88

Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg (2002) 0.85

Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine (2012) 0.85

Growth hormone treatment improves body composition in adults with Prader-Willi syndrome. Clin Endocrinol (Oxf) (2003) 0.84

Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. Growth Horm IGF Res (2003) 0.84

Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol (2011) 0.83

Voice characteristics in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) (2008) 0.83

Associations between amino acids and bone mineral density in men with idiopathic osteoporosis. Bone (2010) 0.82

Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases. J Neurosurg (2004) 0.82

Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab (2004) 0.82

Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab (2002) 0.82

Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism. J Clin Pathol (2013) 0.82

Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr J (2009) 0.81

Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status? Endocrine (2014) 0.81

Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. J Clin Endocrinol Metab (2007) 0.80

Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism. Clin Endocrinol (Oxf) (2012) 0.80

The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency. Clin Endocrinol (Oxf) (2004) 0.79

Eating behavior and gastric emptying in adults with Prader-Willi syndrome. Ann Nutr Metab (2007) 0.79

Voice problems due to virilization in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) (2013) 0.77

Somatropin therapy in adults with Prader-Willi syndrome. Treat Endocrinol (2004) 0.77

The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome. Growth Horm IGF Res (2003) 0.77

Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy. Clin Endocrinol (Oxf) (2014) 0.76

Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients. Growth Horm IGF Res (2005) 0.76

[Guidelines for substitution therapy in pituitary insufficiency in adults]. Lakartidningen (2003) 0.75

Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy. Psychoneuroendocrinology (2012) 0.75

Screening for primary aldosteronism in a primary care unit. J Renin Angiotensin Aldosterone Syst (2012) 0.75